XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Beginning balance, common stock (in shares) at Mar. 31, 2021   53,999,000        
Beginning balance at Mar. 31, 2021 $ 1,358,298 $ 540 $ 499,508 $ (130,732) $ (19,801) $ 1,008,783
Beginning balance, treasury stock (in shares) at Mar. 31, 2021       4,088,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 9,039   9,039      
Exercise of stock options (in shares) 226,000.0 226,000        
Exercise of stock options $ 7,040 $ 2 7,038      
Issuance of shares related to restricted stock (in shares)   205,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       63,000    
Treasury share repurchases (2,916)     $ (2,916)    
Net income (loss) 205,381         205,381
Other comprehensive (loss) income 769       769  
Ending balance, common stock (in shares) at Mar. 31, 2022   54,430,000        
Ending balance at Mar. 31, 2022 1,577,611 $ 544 515,583 $ (133,648) (19,032) 1,214,164
Ending balance, treasury stock (in shares) at Mar. 31, 2022       4,151,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 12,405   12,405      
Exercise of stock options (in shares) 205,200 205,000        
Exercise of stock options $ 7,372 $ 2 7,370      
Issuance of shares related to restricted stock (in shares)   222,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       1,014,000    
Treasury share repurchases (55,466)     $ (55,466)    
Net income (loss) (82,306)         (82,306)
Other comprehensive (loss) income (12,532)       (12,532)  
Ending balance, common stock (in shares) at Mar. 31, 2023   54,857,000        
Ending balance at Mar. 31, 2023 $ 1,447,084 $ 548 535,356 $ (189,114) (31,564) 1,131,858
Ending balance, treasury stock (in shares) at Mar. 31, 2023 5,165,000     5,165,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 14,010   14,010      
Exercise of stock options (in shares) 440,300 441,000        
Exercise of stock options $ 18,089 $ 5 18,084      
Issuance of shares related to restricted stock (in shares)   203,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       515,000    
Treasury share repurchases (30,507)     $ (30,507)    
Net income (loss) 209,339         209,339
Other comprehensive (loss) income (2,931)       (2,931)  
Ending balance, common stock (in shares) at Mar. 31, 2024   55,501,000        
Ending balance at Mar. 31, 2024 $ 1,655,084 $ 555 $ 567,448 $ (219,621) $ (34,495) $ 1,341,197
Ending balance, treasury stock (in shares) at Mar. 31, 2024 5,680,000     5,680,000